tiprankstipranks
Trending News
More News >

Livzon Pharmaceutical Concludes Share Options Cancellation

Story Highlights
Livzon Pharmaceutical Concludes Share Options Cancellation

Don’t Miss TipRanks’ Half-Year Sale

Livzon Pharmaceutical Group ( (HK:1513) ) has provided an update.

Livzon Pharmaceutical Group Inc. has announced the completion of the cancellation of share options under its 2022 Share Options Incentive Scheme. This move, verified by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd., indicates a strategic adjustment in the company’s incentive structure, potentially impacting its financial strategy and shareholder relations.

More about Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality in the healthcare sector.

YTD Price Performance: -2.90%

Technical Sentiment Signal: Sell

Current Market Cap: $3.9B

See more insights into 1513 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1